Botulinum Toxin Injections for ADSD and Chronic Salivary Aspiration

We hope to investigate this treatment prospectively and determine whether patients who do not respond well to treatment may do so with a higher dosage, said Dr. Raval.

References

1. Lange DJ. Systemic effects of botulinum toxin. In: Jankovic J, Hallett M, eds. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, 1994:109-18.

   [Context Link]

2. Blitzer A, Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope; 2001;111(2):218-26.

   [Context Link]

3. Rohrbach S, Laskawi R. Botulinum in ENT medicine. Laryngorhinootologie 2003;82(3);202-13.

   [Context Link]

4. Yin S, Stucker FJ, Nathan CO. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review). J La State Med Soc 2001;153(2):92-7.

   [Context Link]

5. Holden PK, Vokes DE, Taylor MB, Till JA, Crumley RL. Long-term botulinum toxin dose consistency for the treatment of adductor spasmodic dysphonia. Abstract presented at the Combined Otolaryngology Spring Meeting (COSM), April 26, 2007.

   [Context Link]

6. Id. [Context Link]
7. Id. [Context Link]
8. Paniello RC, Barlow J, Serna JS. Longitudinal follow-up of adductor spasmodic dysphonia patients following botulinum toxin injection: quality of life results. Abstract presented at the Combined Otolaryngology Spring Meeting (COSM), April 29, 2007.

   [Context Link]

9. Id. [Context Link]
10. Raval TH, Elliott, CA. Salivary aspiration: a role for botulinum toxin treatment to the salivary glands. Abstract presented at the Combined Otolaryngology Spring Meeting (COSM), April 26, 2007.

    [Context Link]

©2007 The Triological Society